FZD6 and prostate cancer: In a recent study by Han et al., 2018, Luteolin was identified to suppress the Wnt signaling by upregulating frizzled class receptor 6 (FZD6), the negative regulator of β-catenin transcriptional activity, and causing the inhibition of the stemness of prostate cancer cells [79].